Mycophenolate mofetil oral (Azurity Pharmaceuticals)

N/A

Report date: 2024/06/11 20:00:08

Base Information

Drug NameMycophenolate mofetil oral (Azurity Pharmaceuticals)
Drug Alias NameMycophenolate mofetil oral suspension(Azurity Pharmaceuticals)Myhibbin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors
TargetsInosine-5'-monophosphate dehydrogenase (IMPDH)
Therapy Area/IndicationsRejection of renal transplantationRejection of liver transplantation
Global Approved IndicationsRejection of renal transplantationRejection of liver transplantation
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/05/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAzurity Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAzurity Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsRejection of renal transplantationRejection of liver transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A